Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Insufficient sleep and fitness to drive in shift workers: A systematic literature review.

Knott M, Classen S, Krasniuk S, Tippett M, Alvarez L.

Accid Anal Prev. 2019 Aug 20:105234. doi: 10.1016/j.aap.2019.07.010. [Epub ahead of print]

PMID:
31443915
2.

Mechanistic Effect Modeling Approach for the Extrapolation of Species Sensitivity.

Gergs A, Rakel KJ, Liesy D, Zenker A, Classen S.

Environ Sci Technol. 2019 Aug 20;53(16):9818-9825. doi: 10.1021/acs.est.9b01690. Epub 2019 Aug 9.

PMID:
31356070
3.

Clinical Utility of the DriveFocus™ Intervention on Young Drivers With and Without Experience.

Alvarez L, Classen S, Medhizadah S.

Front Public Health. 2019 May 24;7:123. doi: 10.3389/fpubh.2019.00123. eCollection 2019.

4.

An Integrative Review on Teen Distracted Driving for Model Program Development.

Classen S, Winter SM, Brown C, Morgan-Daniel J, Medhizadah S, Agarwal N.

Front Public Health. 2019 May 3;7:111. doi: 10.3389/fpubh.2019.00111. eCollection 2019. Review.

5.

Corrigendum: Construction and Validation of the 21 Item Fitness-to-Drive Screening Measure Short-Form.

Classen S, Medhizadah S, Romero S, Lee MJ.

Front Public Health. 2019 Apr 16;7:86. doi: 10.3389/fpubh.2019.00086. eCollection 2019.

6.

Author Correction: Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system.

Kaur H, Carvalho J, Looso M, Singh P, Chennupati R, Preussner J, Günther S, Albarrán-Juárez J, Tischner D, Classen S, Offermanns S, Wettschureck N.

Nat Commun. 2019 Mar 28;10(1):1448. doi: 10.1038/s41467-019-09334-3.

7.

Visual Attention Cut Points for Driver Fitness in Parkinson's Disease.

Classen S, Brumback B, Crawford K, Jenniex S.

OTJR (Thorofare N J). 2019 Oct;39(4):257-265. doi: 10.1177/1539449219836689. Epub 2019 Mar 24.

PMID:
30907280
8.

The Concurrent Criterion Validity of the 32-Item Fitness-to-Drive Screening Measure.

Medhizadah S, Classen S, Johnson AM.

Front Psychol. 2019 Feb 14;10:253. doi: 10.3389/fpsyg.2019.00253. eCollection 2019.

9.

OTJR: 2018 Milestones and Progress Towards Preeminence.

Classen S, Krasniuk S.

OTJR (Thorofare N J). 2019 Jan;39(1):3-4. doi: 10.1177/1539449218818674. No abstract available.

PMID:
30798773
10.

Smart In-Vehicle Technologies and Older Drivers: A Scoping Review.

Classen S, Jeghers M, Morgan-Daniel J, Winter S, King L, Struckmeyer L.

OTJR (Thorofare N J). 2019 Apr;39(2):97-107. doi: 10.1177/1539449219830376. Epub 2019 Feb 22.

PMID:
30791814
11.

Development and Validation of Ambulosono: A Wearable Sensor for Bio-Feedback Rehabilitation Training.

Chomiak T, Sidhu AS, Watts A, Su L, Graham B, Wu J, Classen S, Falter B, Hu B.

Sensors (Basel). 2019 Feb 8;19(3). pii: E686. doi: 10.3390/s19030686.

12.

Clinical Determinants of Fitness to Drive in Persons With Multiple Sclerosis: Systematic Review.

Krasniuk S, Classen S, Morrow SA, Tippett M, Knott M, Akinwuntan A.

Arch Phys Med Rehabil. 2019 Aug;100(8):1534-1555. doi: 10.1016/j.apmr.2018.12.029. Epub 2019 Jan 26. Review.

PMID:
30690007
13.

Construction and Validation of the 21 Item Fitness-to-Drive Screening Measure Short-Form.

Classen S, Medhizadah S, Romero S, Lee MJ.

Front Public Health. 2018 Dec 6;6:339. doi: 10.3389/fpubh.2018.00339. eCollection 2018. Erratum in: Front Public Health. 2019 Apr 16;7:86.

14.

Insufficient sleep and fitness to drive in shift workers: a systematic literature review protocol.

Knott M, Classen S, Krasniuk S, Tippett M, Alvarez L.

Inj Prev. 2018 Dec 15. pii: injuryprev-2018-042972. doi: 10.1136/injuryprev-2018-042972. [Epub ahead of print]

PMID:
30554167
15.

Functional and Structural Resilience of the Active Site Loop in the Evolution of Plasmodium Lactate Dehydrogenase.

Wirth JD, Boucher JI, Jacobowitz JR, Classen S, Theobald DL.

Biochemistry. 2018 Nov 13;57(45):6434-6442. doi: 10.1021/acs.biochem.8b00913. Epub 2018 Nov 2.

16.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
17.

Feasibility of DriveFocus™ and Driving Simulation Interventions in Young Drivers.

Alvarez L, Classen S, Medhizadah S, Knott M, Asantey K, He W, Feher A, Moulin MS.

OTJR (Thorofare N J). 2018 Oct;38(4):245-253. doi: 10.1177/1539449218787495. Epub 2018 Jul 15.

PMID:
30009688
18.

Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.

Neumann E, Schwarz MC, Hasseli R, Hülser ML, Classen S, Sauerbier M, Rehart S, Mueller-Ladner U.

Ann Rheum Dis. 2018 Nov;77(11):1619-1626. doi: 10.1136/annrheumdis-2018-212954. Epub 2018 Jul 6.

PMID:
29980577
19.

Pilot Efficacy of a DriveFocus™ Intervention on the Driving Performance of Young Drivers.

Alvarez L, Classen S, Medhizadah S, Knott M, He W.

Front Public Health. 2018 May 4;6:125. doi: 10.3389/fpubh.2018.00125. eCollection 2018.

21.

An International Approach to Enhancing a National Guideline on Driving and Dementia.

Rapoport MJ, Chee JN, Carr DB, Molnar F, Naglie G, Dow J, Marottoli R, Mitchell S, Tant M, Herrmann N, Lanctôt KL, Taylor JP, Donaghy PC, Classen S, O'Neill D.

Curr Psychiatry Rep. 2018 Mar 12;20(3):16. doi: 10.1007/s11920-018-0879-x. Review.

PMID:
29527643
22.

Editorial: Growth and Advances of OTJR.

Classen S.

OTJR (Thorofare N J). 2018 Jan;38(1):3-5. doi: 10.1177/1539449217747419. No abstract available. Erratum in: OTJR (Thorofare N J). 2018 Jul;38(3):219.

PMID:
29254459
23.

Transportation and Aging: An Updated Research Agenda for Advancing Safe Mobility.

Dickerson AE, Molnar L, Bedard M, Eby DW, Classen S, Polgar J.

J Appl Gerontol. 2017 Oct 1:733464817739154. doi: 10.1177/0733464817739154. [Epub ahead of print]

PMID:
29165017
24.

Constructing the 32-item Fitness-to-Drive Screening Measure.

Medhizadah S, Classen S, Johnson AM.

OTJR (Thorofare N J). 2018 Apr;38(2):89-95. doi: 10.1177/1539449217741136. Epub 2017 Nov 10.

PMID:
29126376
25.

Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis.

Chee JN, Rapoport MJ, Molnar F, Herrmann N, O'Neill D, Marottoli R, Mitchell S, Tant M, Dow J, Ayotte D, Lanctôt KL, McFadden R, Taylor JP, Donaghy PC, Olsen K, Classen S, Elzohairy Y, Carr DB.

Am J Geriatr Psychiatry. 2017 Dec;25(12):1376-1390. doi: 10.1016/j.jagp.2017.05.007. Epub 2017 May 15. Review.

PMID:
28917504
26.

Guiding Framework for Driver Assessment Using Driving Simulators.

Campos JL, Bédard M, Classen S, Delparte JJ, Hebert DA, Hyde N, Law G, Naglie G, Yung S.

Front Psychol. 2017 Aug 22;8:1428. doi: 10.3389/fpsyg.2017.01428. eCollection 2017. No abstract available.

27.

Reflecting and Refocusing: Responsibilities of Thought Leadership.

Classen S, Alvarez L.

OTJR (Thorofare N J). 2017 Jan;37(1):3-4. doi: 10.1177/1539449216683055. No abstract available.

PMID:
28830314
28.

On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study.

Morrow SA, Classen S, Monahan M, Danter T, Taylor R, Krasniuk S, Rosehart H, He W.

Mult Scler. 2018 Oct;24(11):1499-1506. doi: 10.1177/1352458517723991. Epub 2017 Aug 7.

PMID:
28782411
29.

Visual Correlates of Fitness to Drive in Adults With Multiple Sclerosis.

Classen S, Krasniuk S, Morrow SA, Alvarez L, Monahan M, Danter T, Rosehart H.

OTJR (Thorofare N J). 2018 Jan;38(1):15-27. doi: 10.1177/1539449217718841. Epub 2017 Aug 2.

PMID:
28766462
30.

Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system.

Kaur H, Carvalho J, Looso M, Singh P, Chennupati R, Preussner J, Günther S, Albarrán-Juárez J, Tischner D, Classen S, Offermanns S, Wettschureck N.

Nat Commun. 2017 Jun 16;8:15700. doi: 10.1038/ncomms15700. Erratum in: Nat Commun. 2019 Mar 28;10(1):1448.

31.

Driving Errors That Predict On-Road Outcomes in Adults With Multiple Sclerosis.

Krasniuk S, Classen S, Morrow SA, Monahan M, Danter T, Rosehart H, He W.

OTJR (Thorofare N J). 2017 May 1:1539449217708554. doi: 10.1177/1539449217708554. [Epub ahead of print]

PMID:
28539098
32.

Editorial: OTJR's Journey in Becoming a World-Class Journal.

Classen S.

OTJR (Thorofare N J). 2017 Apr;37(2):59-61. doi: 10.1177/1539449217699539. No abstract available.

PMID:
28326984
33.

Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride.

Schedler K, Assadian O, Brautferger U, Müller G, Koburger T, Classen S, Kramer A.

BMC Infect Dis. 2017 Feb 13;17(1):143. doi: 10.1186/s12879-017-2220-4.

34.

Interrater reliability of Western University's on-road assessment.

Classen S, Krasniuk S, Knott M, Alvarez L, Monahan M, Morrow S, Danter T.

Can J Occup Ther. 2016 Dec;83(5):317-325. doi: 10.1177/0008417416663228.

PMID:
28050933
35.

Driving Intervention for Returning Combat Veterans.

Classen S, Winter S, Monahan M, Yarney A, Link Lutz A, Platek K, Levy C.

OTJR (Thorofare N J). 2017 Apr;37(2):62-71. doi: 10.1177/1539449216675582. Epub 2016 Nov 29.

PMID:
27830643
36.

Development and Validity of Western University's On-Road Assessment.

Classen S, Krasniuk S, Alvarez L, Monahan M, Morrow SA, Danter T.

OTJR (Thorofare N J). 2017 Jan;37(1):14-29. doi: 10.1177/1539449216672859. Epub 2016 Oct 15.

PMID:
27744272
37.

Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.

Richter MJ, Ewert R, Warnke C, Gall H, Classen S, Grimminger F, Mayer E, Seeger W, Ghofrani HA.

Clin Res Cardiol. 2017 Mar;106(3):174-182. doi: 10.1007/s00392-016-1037-2. Epub 2016 Sep 26.

PMID:
27670656
38.

Clinical Assessments as Predictors of Primary On-Road Outcomes in Parkinson's Disease.

Classen S, Holmes JD, Alvarez L, Loew K, Mulvagh A, Rienas K, Walton V, He W.

OTJR (Thorofare N J). 2015 Oct;35(4):213-20. doi: 10.1177/1539449215601118. Epub 2015 Aug 13.

PMID:
27505901
39.

Editorial: Evidence-Informed Reviews-Moving Occupational Therapy Practice and Science Forward.

Classen S, Alvarez L.

OTJR (Thorofare N J). 2015 Oct;35(4):199-203. doi: 10.1177/1539449215607431. No abstract available.

PMID:
27505899
40.

Developing a Canadian-Specific Version of the Fitness-to-Drive Screening Measure©.

Classen S, Alvarez L, Ferreira PJ, Chen CH, Meyer CK, Nywening AG.

OTJR (Thorofare N J). 2016 Apr;36(2):82-91. doi: 10.1177/1539449216650462.

PMID:
27504881
41.

Caregivers' Impressions Predicting Fitness to Drive in Persons With Parkinson's.

Classen S, Alvarez L.

OTJR (Thorofare N J). 2016 Jan;36(1):5-13. doi: 10.1177/1539449215601117. Epub 2015 Aug 18.

PMID:
27504688
42.

Editorial: Indicators of OTJR's Growth and Success.

Classen S.

OTJR (Thorofare N J). 2016 Jan;36(1):3-4. doi: 10.1177/1539449215623788. No abstract available.

PMID:
27504687
43.

The IgG1 B-cell receptor provides survival and proliferative signals analogue to the Igα but not the Igβ co-receptor.

Song J, Uyttersprot N, Classen S, Waisman A.

Eur J Immunol. 2016 Aug;46(8):1878-86. doi: 10.1002/eji.201646396. Epub 2016 Jul 18.

44.

ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling.

Deshpande RA, Williams GJ, Limbo O, Williams RS, Kuhnlein J, Lee JH, Classen S, Guenther G, Russell P, Tainer JA, Paull TT.

EMBO J. 2016 Apr 1;35(7):791. doi: 10.15252/embj.201694047. No abstract available.

45.

Psychometrics of the Fitness-to-Drive Screening Measure.

Classen S, Velozo CA, Winter SM, Bédard M, Wang Y.

OTJR (Thorofare N J). 2015 Jan;35(1):42-52.

PMID:
26623476
46.

Editorial: Valuing the Past, Investing in the Future.

Classen S.

OTJR (Thorofare N J). 2015 Jan;35(1):3-4. No abstract available.

PMID:
26623473
47.

Incubators of Innovation, Accelerators of Opportunities.

Classen S.

OTJR (Thorofare N J). 2015 Apr;35(2):71-2. No abstract available.

PMID:
26460468
48.

Ecological Recovery Potential of Freshwater Organisms: Consequences for Environmental Risk Assessment of Chemicals.

Gergs A, Classen S, Strauss T, Ottermanns R, Brock TC, Ratte HT, Hommen U, Preuss TG.

Rev Environ Contam Toxicol. 2016;236:259-94. doi: 10.1007/978-3-319-20013-2_5.

PMID:
26423077
49.

Efficacy of an occupational therapy driving intervention for returning combat veterans.

Classen S, Cormack NL, Winter SM, Monahan M, Yarney A, Lutz AL, Platek K.

OTJR (Thorofare N J). 2014 Fall;34(4):177-82. doi: 10.3928/15394492-20141006-01.

PMID:
25347755
50.

The R-factor gap in macromolecular crystallography: an untapped potential for insights on accurate structures.

Holton JM, Classen S, Frankel KA, Tainer JA.

FEBS J. 2014 Sep;281(18):4046-60. doi: 10.1111/febs.12922. Epub 2014 Sep 17.

Supplemental Content

Loading ...
Support Center